September 20, 2018
The EU grant will “support development and streamlined integration of 3D printing technologies to enable advanced medical treatment and its widespread application”
Oxford, UK, 20 September 2018 – Oxford MEStar today announced that it has been awarded funding to take part in a 36-month, € 6.84 Million project under the European Union Interreg 2 Seas initiative.
3DMed aims to improve affordability and large-scale accessibility of medical treatment using 3D printed devices. 15 Partners, including top universities and innovative companies in the Netherlands, Belgium, France and the UK will join forces in an unprecedented exercise to explore the full potential of the 3D printing technology for advanced medical care.
The project aims to deliver three major objectives:
- Enabling Streamlined care by integrating diagnosis, design and manufacturing of 3DP medical devices and post operatory evaluation into a validated software platform. This will enable reduction of lead times from 6-8 weeks currently to 6-8 days in by 2021 and to 24 hours in 2023.
- Personalized medical devices (prostheses, implants, orthoses), designed using the images acquired for individual patients. Using 3D printing technology to produce these customised devices will also trigger a drop in the cost of the device by as much as 90%. The cost of medical treatment will also decrease by 30%.
- Complex shapes and miniaturized geometries for implants and surgical instruments, as well as functionalised devices to enhance treatment effectiveness and post-treatment recovery.
More information about the project can be found here https://www.interreg2seas.eu/nl/3dmed
